Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer

Clinical trial NCT02653313 · COMPLETED

Trial details

NCT number: NCT02653313
Sponsor: Oryx GmbH & Co. KG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal

Start date: 2015-12-01
Primary completion: 2018-05-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.